Wealthcome raised €15M in a Series B round announced on September 24, 2026. Wealthcome develops a comprehensive SaaS solution for digitizing and automating wealth management.
Wealthcome develops a comprehensive SaaS solution for digitizing and automating wealth management.
Wealthcome, based in Bordeaux, France, announced €15M in Series B financing on September 24, 2026.
Participants include Blackfin Capital Partners, Breega.
AI medical assistants and clinical workflow software for healthcare providers.
AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure.